Ensem Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors (NCT06993844) | Ensem Therapeutics | 2025-06-10 |
Track Ensem Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.